Traveler examining malaria parasites with magnifying glass

Malaria Detection: A New LAMP Test for Travelers

"Discover how a commercial LAMP test offers a faster, more accurate way to rule out malaria in returning travelers, reducing healthcare costs and improving patient care."


Malaria, a disease affecting millions worldwide, demands accurate and timely diagnosis. Traditionally, healthcare providers have relied on microscopy and rapid diagnostic tests (RDTs). However, these methods have limitations, especially in non-endemic areas like North America, where the vast majority of tests come back negative.

A new study published in Open Forum Infectious Diseases explores the potential of loop-mediated isothermal amplification (LAMP) assays to improve malaria detection in returning travelers. This prospective diagnostic trial, conducted between June 2017 and January 2018, compares the Meridian illumigene Malaria assay with conventional microscopy and RDTs, offering a promising alternative for ruling out malaria with greater accuracy and efficiency.

The study enrolled 298 patients presenting with malaria-like symptoms. Researchers sought to evaluate the clinical performance of the LAMP test against microscopy and RDTs. The findings highlight the LAMP assay's potential to transform malaria diagnostics, offering a faster, more sensitive method for healthcare providers.

LAMP Assay: A New Diagnostic Tool

Traveler examining malaria parasites with magnifying glass

The study’s results indicate that the LAMP assay has a high sensitivity and specificity compared to traditional microscopy. In the prospective arm of the study, LAMP demonstrated a sensitivity of 98.1% (95% CI, 90.0%-100%) and a specificity of 97.6% (95% CI, 95.2%-99.1%) against microscopy. After discrepant resolution using real-time polymerase chain reaction (PCR), the LAMP test achieved 100% sensitivity and specificity.

In contrast, RDTs showed a sensitivity of 83.3% (95% CI, 58.6%–96.4%) and a specificity of 96.2% (95% CI, 93.2%-98.1%) after discrepant resolution. These findings suggest that LAMP assay could offer a more reliable method for excluding malaria in returning travelers.
  • Improved Sensitivity: LAMP showed higher sensitivity than RDTs.
  • High Specificity: LAMP maintained high specificity, minimizing false positives.
  • Reduced Repeat Testing: LAMP’s accuracy could reduce the need for repeat testing.
  • Faster Results: LAMP offers quicker turnaround times.
Researchers also investigated the cost-effectiveness of implementing LAMP in a diagnostic algorithm. The analysis suggested potential savings of up to USD$13 per specimen. This is due to reduced labor costs and fewer repeat tests. Integrating LAMP into routine diagnostic procedures can optimize resource allocation and improve overall efficiency.

Implications for Malaria Diagnostics

The study underscores the limitations of traditional malaria diagnostic methods and highlights the potential of the LAMP assay to improve diagnostic accuracy and efficiency. By implementing LAMP, healthcare providers can reduce the need for repeat testing, lower healthcare costs, and provide faster results. This approach ultimately improves patient care and supports malaria elimination efforts in non-endemic regions.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.